Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations

by Geng Y, Mei Y, Xi Y, Yu J, Meng K, Zhang T, Ma W
Published 2020-10-01

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma

by Wang H, Chen S, Meng D, Wu C, Zhu J, Jiang M, Ning J, Wu S, Wu L, Li J, Chen B, Zhao S, Li W, Yu J, Fang Q, Zhu J, Zhao W, He Y, Zhou C
Published 2021-05-01

Radiotherapy for patients with completely resected pathologic IIIA(N2) non–small-cell lung cancer: a retrospective analysis

by Zhu Y, Fu L, Jing W, Kong L, Yu J
Published 2019-12-01

Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study

by An N, Wang H, Li J, Zhai X, Jing W, Jia W, Kong L, Zhu H, Yu J
Published 2019-10-01

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

by Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J
Published 2018-07-01

Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review

by Chen S, He Y, Liu J, Chen X, Yu J, Li W, Chen B, Sun C, Zhou C
Published 2019-12-01

Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report

by An N, Wang H, Zhu H, Yan W, Jing W, Kong L, Zhang Y, Yu J
Published 2019-09-01